By Amanda Sealy | CNN The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series. Pfizer requested this EUA at the end of April, citing company data that showed […]
The post FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11 appeared first on The Atlanta Voice.